Drugs / Feru-guard 100M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03451760 | Sep 2018 → Dec 2019 | — | Glovia Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Feru-guard 100M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03451760 ↗ |
| Route | Oral | “participants will take two 280 mg hard gel capsules of Feru-guard 100M per day” NCT03451760 ↗ |